GDTC logo

CytoMed Therapeutics Limited (GDTC) Cash From Financing

Annual CFF

$8.13 M
+$7.43 M+1056.64%

31 December 2023

GDTC Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GDTC Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1056.6%--
3 y3 years+495.1%--
5 y5 years---

GDTC Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+1056.6%
5 y5 yearsat high+1056.6%
alltimeall timeat high+1056.6%

CytoMed Therapeutics Limited Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2023
$8.13 M(+1056.6%)
-
-
Dec 2022
$702.90 K(-77.4%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
$3.11 M(+127.3%)
-
-
Dec 2020
$1.37 M
-
-

FAQ

  • What is CytoMed Therapeutics Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for CytoMed Therapeutics Limited?
  • What is CytoMed Therapeutics Limited annual CFF year-on-year change?

What is CytoMed Therapeutics Limited annual cash flow from financing activities?

The current annual CFF of GDTC is $8.13 M

What is the all time high annual CFF for CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited all-time high annual cash flow from financing activities is $8.13 M

What is CytoMed Therapeutics Limited annual CFF year-on-year change?

Over the past year, GDTC annual cash flow from financing activities has changed by +$7.43 M (+1056.64%)